Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).
Witz F, Sadoun A, Perrin MC, Berthou C, Brière J, Cahn JY, Lioure B, Witz B, François S, Desablens B, Pignon B, Le Prisé PY, Audhuy B, Caillot D, Casassus P, Delain M, Christian B, Tellier Z, Polin V, Hurteloup P, Harousseau JL. Witz F, et al. Among authors: polin v. Blood. 1998 Apr 15;91(8):2722-30. Blood. 1998. PMID: 9531581 Free article. Clinical Trial.
Treatment of acute myelogenous leukaemia in patients aged 50-65: idarubicin is more effective than zorubicin for remission induction and prolonged disease-free survival can be obtained using a unique consolidation course. The Goelam Group.
Pignon B, Witz F, Desablens B, Leprise PY, Francois S, Linassier C, Berthou C, Caillot D, Lioure B, Cahn JY, Casassus P, Sadoun A, Audhuy B, Guyotat D, Briere J, Vilque JP, Baranger L, Polin V, Berthaud P, Hurteloup P, Herve P, Harousseau JL. Pignon B, et al. Among authors: polin v. Br J Haematol. 1996 Aug;94(2):333-41. doi: 10.1046/j.1365-2141.1996.d01-1803.x. Br J Haematol. 1996. PMID: 8759894 Clinical Trial.
Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study.
Pujol JL, Douillard JY, Rivière A, Quoix E, Lagrange JL, Berthaud P, Bardonnet-Comte M, Polin V, Gautier V, Milleron B, Chomy F, Chomy P, Spaeth D, Le Chevalier T. Pujol JL, et al. Among authors: polin v. J Clin Oncol. 1997 May;15(5):2082-9. doi: 10.1200/JCO.1997.15.5.2082. J Clin Oncol. 1997. PMID: 9164221 Clinical Trial.
Prognostic factors associated with upper gastrointestinal bleeding based on the French multicenter SANGHRIA trial.
Quentin V, Remy AJ, Macaigne G, Leblanc-Boubchir R, Arpurt JP, Prieto M, Koudougou C, Tsakiris L, Grasset D, Vitte RL, Cuen D, Verlynde J, Elriz K, Ripault MP, Ehrhard F, Baconnier M, Herrmann S, Talbodec N, Lam YH, Bideau K, Costes L, Skinazi F, Touze I, Heresbach D, Lahmek P, Nahon S; Members of the Association Nationale des Hépato-gastroentérologues des Hôpitaux Généraux (ANGH) SANGHRIA Study Group. Quentin V, et al. Endosc Int Open. 2021 Sep 16;9(10):E1504-E1511. doi: 10.1055/a-1508-5871. eCollection 2021 Oct. Endosc Int Open. 2021. PMID: 34540542 Free PMC article.
Iron deficiency: from diagnosis to treatment.
Polin V, Coriat R, Perkins G, Dhooge M, Abitbol V, Leblanc S, Prat F, Chaussade S. Polin V, et al. Dig Liver Dis. 2013 Oct;45(10):803-9. doi: 10.1016/j.dld.2013.02.019. Epub 2013 Apr 11. Dig Liver Dis. 2013. PMID: 23582772 Review.
15 results